XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Baxter stockholders' equity
Total Baxter stockholders' equity
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Common stock in treasury
Additional contributed capital
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Noncontrolling interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adoption of new accounting standard $ 7,912 $ (4) $ 7,882 $ (4) $ 683 $ (10,764) $ 5,955 $ 15,718 $ (4) $ (3,710) $ 30
Beginning of period (in shares) at Dec. 31, 2019         683,000,000            
Beginning of period at Dec. 31, 2019 7,912 $ (4) 7,882 $ (4) $ 683 $ (10,764) 5,955 15,718 $ (4) (3,710) 30
Beginning of period, treasury shares (in shares) at Dec. 31, 2019           177,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 580   578         578     2
Other comprehensive income (loss) (278)   (278)             (278)  
Stock issued under employee benefit plans and other (in shares)           (4,000,000)          
Stock issued under employee benefit plans and other 187   187     $ 167 20        
Dividends declared on common stock (237)   (237)         (237)      
End of period (in shares) at Jun. 30, 2020         683,000,000            
End of period at Jun. 30, 2020 $ 8,160   8,128   $ 683 $ (10,597) 5,975 16,055   (3,988) 32
End of period, treasury shares (in shares) at Jun. 30, 2020           173,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adoption of new accounting standard us-gaap:AccountingStandardsUpdate201613Member                    
Adoption of new accounting standard $ 7,730   7,699   $ 683 $ (10,677) 5,935 15,935   (4,177) 31
Beginning of period (in shares) at Mar. 31, 2020         683,000,000            
Beginning of period at Mar. 31, 2020 7,730   7,699   $ 683 $ (10,677) 5,935 15,935   (4,177) 31
Beginning of period, treasury shares (in shares) at Mar. 31, 2020           175,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 247   246         246     1
Other comprehensive income (loss) 189   189             189  
Stock issued under employee benefit plans and other (in shares)           (2,000,000)          
Stock issued under employee benefit plans and other 120   120     $ 80 40        
Dividends declared on common stock (126)   (126)         (126)      
End of period (in shares) at Jun. 30, 2020         683,000,000            
End of period at Jun. 30, 2020 8,160   8,128   $ 683 $ (10,597) 5,975 16,055   (3,988) 32
End of period, treasury shares (in shares) at Jun. 30, 2020           173,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adoption of new accounting standard 8,160   8,128   683 $ (10,597) 5,975 16,055   (3,988) 32
Adoption of new accounting standard $ 8,726   8,689   $ 683 (11,051) 6,043 16,328   (3,314) 37
Beginning of period (in shares) at Dec. 31, 2020 683,494,944       683,000,000            
Beginning of period at Dec. 31, 2020 $ 8,726   8,689   $ 683 $ (11,051) 6,043 16,328   (3,314) 37
Beginning of period, treasury shares (in shares) at Dec. 31, 2020 178,580,208         179,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income $ 601   596         596     5
Other comprehensive income (loss) $ (62)   (62)             (62)  
Purchases of treasury stock (in shares) 7,300,000         7,000,000          
Purchases of treasury stock $ (600)   (600)     $ (600) 0        
Stock issued under employee benefit plans and other (in shares)           (2,000,000)          
Stock issued under employee benefit plans and other 137   137     $ 90 47 0      
Dividends declared on common stock (266)   (266)         (266)      
Change in noncontrolling interests $ (1)                   (1)
End of period (in shares) at Jun. 30, 2021 683,494,944       683,000,000            
End of period at Jun. 30, 2021 $ 8,535   8,494   $ 683 $ (11,561) 6,090 16,658   (3,376) 41
End of period, treasury shares (in shares) at Jun. 30, 2021 183,639,786         184,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adoption of new accounting standard $ 8,490   8,452   $ 683 $ (11,296) 6,043 16,502   (3,480) 38
Beginning of period (in shares) at Mar. 31, 2021         683,000,000            
Beginning of period at Mar. 31, 2021 8,490   8,452   $ 683 $ (11,296) 6,043 16,502   (3,480) 38
Beginning of period, treasury shares (in shares) at Mar. 31, 2021           181,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 301   298         298     3
Other comprehensive income (loss) 104   104             104  
Purchases of treasury stock (in shares)           3,000,000          
Purchases of treasury stock (300)   (300)     $ (300)          
Stock issued under employee benefit plans and other (in shares)           0          
Stock issued under employee benefit plans and other 82   82     $ 35 47        
Dividends declared on common stock $ (142)   (142)         (142)      
End of period (in shares) at Jun. 30, 2021 683,494,944       683,000,000            
End of period at Jun. 30, 2021 $ 8,535   8,494   $ 683 $ (11,561) 6,090 16,658   (3,376) 41
End of period, treasury shares (in shares) at Jun. 30, 2021 183,639,786         184,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Adoption of new accounting standard $ 8,535   $ 8,494   $ 683 $ (11,561) $ 6,090 $ 16,658   $ (3,376) $ 41